Supriya Lifescience Limited (SUPRIYA) Share Price
NSE · Healthcare · Biotechnology · ISIN INE07RO01027
Key metrics
- Market Cap
- ₹6,464 Cr
- P/E Ratio
- 32.56
- EPS
- 24.67
- Book Value
- 148.82
- P/B Ratio
- 5.36
- ROE
- 17.46%
- ROCE
- 22.08%
- Debt / Equity
- 0
- Net Margin
- 25.26%
- Revenue Growth
- 18.86%
- Profit Growth
- 11.26%
- Dividend Yield
- 0.13%
- 52W High
- ₹1,085.00
- 52W Low
- ₹545.50
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Supriya Lifescience Limited
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 71.28%
The full Supriya Lifescience Limited analysis
Create a free account to open the complete SUPRIYA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.